Recordati Industria Chimica e Farmaceutica SpA
XBER:RER1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
XBER:RER1
|
IT |
|
E
|
Essential Utilities Inc
XBER:A2A
|
US |
|
Sanlam Ltd
F:LA6A
|
ZA |
|
B3 Consulting Group AB (publ)
F:B37
|
SE |
|
Paramount Global
F:0VVB
|
US |
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
A
|
Alpha Services and Holdings SA
XBER:ACBB
|
GR |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
Atlas Copco AB
LSE:0XXT
|
SE |
|
R
|
Rewalk Robotics Ltd
F:2RW
|
IL |
|
A
|
Anhui Conch Cement Co Ltd
XMUN:AQE
|
CN |
|
Stora Enso Oyj
F:ENUN
|
FI |
|
H
|
Hasbro Inc
SWB:HAS
|
US |
|
L
|
Lands End Inc
SWB:LED
|
US |
|
Isuzu Motors Ltd
F:ISU
|
JP |
|
G
|
Gecina SA
SWB:GI6A
|
FR |
|
Grifols SA
F:G0FB
|
ES |
|
A
|
American Superconductor Corp
F:AMS1
|
US |
|
Borregaard ASA
F:BO4
|
NO |
|
Yoc AG
F:YOC
|
DE |
|
N
|
Nomura Holdings Inc
SWB:NSE
|
JP |
Wall St Price Targets
RER1 Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for RER1 is 52.45 EUR with a low forecast of 42.34 EUR and a high forecast of 65.1 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RER1's stock price target?
Price Target
52.45
EUR
According to Wall Street analysts, the average 1-year price target for RER1 is 52.45 EUR with a low forecast of 42.34 EUR and a high forecast of 65.1 EUR.
What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 20%.
